Essential medicines and health products

Thirty-sixth meeting of the Expert Committee on Drug Dependence


Agenda items 4.1-4.4

4. CRITICAL REVIEW OF PSYCHOACTIVE SUBSTANCES

4.1: Tapentadol*

4.2: N-benzylpiperazine (BZP)*

4.3: Gamma-butyrolactone (GBL)*

4.4: 1,4-Butanediol (I,4 BD)*

* Pre review recommendation @ CND resolution INCB request
Share